Today's ASX's Top 10 Quarterly Momentum Stocks: Rhythm Biosciences Limited Falcon Metals Limited Lumos Diagnostics Holdings Limited Locksley Resources Limited GBM Resources Limited Black Canyon Limited Electro Optic Systems Holdings Limited Forrestania Resources Limited Viridis Mining and Minerals Limited 4DMedical Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Lumos Diagnostics Holdings Limited Locksley Resources Limited Viridis Mining and Minerals Limited Forrestania Resources Limited Falcon Metals Limited Noxopharm Limited PolarX Limited dorsaVi Ltd Torque Metals Limited DroneShield Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Lumos Diagnostics Holdings Limited Locksley Resources Limited Viridis Mining and Minerals Limited Forrestania Resources Limited Falcon Metals Limited Noxopharm Limited PolarX Limited dorsaVi Ltd Torque Metals Limited DroneShield Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Locksley Resources Limited dorsaVi Ltd Lumos Diagnostics Holdings Limited Viridis Mining and Minerals Limited Forrestania Resources Limited PolarX Limited Torque Metals Limited Peak Minerals Limited Anson Resources Limited Impact Minerals Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

China's stranglehold on rare earth processing—controlling 90% of global capacity—faces its biggest challenge yet as the Pentagon invests $400 million in American rare earth independence and ASX companies deliver explosive quarterly gains up to 134%. This episode explores how Beijing weaponised critical minerals through December 2024 export bans on gallium and germanium, followed by April 2025 restrictions on seven rare earth elements essential for military applications—from F-35 fighter jets to missile guidance systems.

We analyse four ASX leaders capitalising on this geopolitical shift: Metallium's revolutionary Flash Joule Heating technology enabling US critical metals recovery, Victory Metals' massive Australian heavy rare earth resource attracting US government backing, Lynas breaking China's processing monopoly with first dysprosium production outside Beijing, and Green Critical Minerals' diversified critical minerals platform. With quarterly returns ranging from 29% to 134% and government funding reaching unprecedented levels, these companies are literally rebuilding the technological foundation of Western military and economic independence from Chinese supply chains.

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Black Canyon Limited Viridis Mining and Minerals Limited dorsaVi Ltd Lumos Diagnostics Holdings Limited Resolution Minerals Limited Anson Resources Limited PPK Group Limited Clarity Pharmaceuticals Ltd DroneShield Limited Emyria Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Viridis Mining and Minerals Limited NeuroScientific Biopharmaceuticals Limited Mad Paws Holdings Limited PPK Group Limited Black Canyon Limited Resolution Minerals Limited Peregrine Gold Limited Falcon Metals Limited dorsaVi Ltd Micro-X Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: NeuroScientific Biopharmaceuticals Limited Viridis Mining and Minerals Limited Resolution Minerals Limited Mad Paws Holdings Limited Black Canyon Limited Noxopharm Limited Peak Minerals Limited Patriot Battery Metals Inc. G50 Corp Limited Falcon Metals Limited

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

This week's episode explores the ASX therapeutic innovation sector experiencing extraordinary momentum, featuring six breakthrough companies: Nyrada (NYR) with a stunning 123% quarterly and 189% yearly surge following clinical trial progressions, Mesoblast (MSB) delivering 189% yearly gains after achieving the first-ever FDA stem cell therapy approval, Bioxyne (BXN) up 228% over twelve months with its diversified pharmaceutical manufacturing platform, Aroa Biosurgery (ARX) advancing wound healing innovations, Neuren Pharmaceuticals (NEU) maintaining leadership in neurodevelopmental treatments, and Biome Australia (BIO) capitalising on the probiotic therapeutics trend.

The discussion covers how global money is rotating from AI into healthcare, creating a 3-5 year innovation cycle that's benefiting ASX companies developing everything from regenerative medicines to neurodevelopmental treatments. We analyse how regulatory momentum is accelerating, with companies successfully executing US-first, then international expansion strategies.

Key themes include FDA approval breakthroughs validating new therapeutic categories, European market expansion opportunities, and increasing pharmaceutical partnership activity. The episode reveals why this sector offers diversified exposure to the most promising areas of modern medicine, from commercialised success stories to high-potential development opportunities.

Disclaimer: This is not advice, seek professional assistance before acting on this information. AI and human resources have been used to generate this content from sources believed to be accurate. 

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.

Today's ASX's Top 10 Quarterly Momentum Stocks: Lumos Diagnostics Holdings Limited NeuroScientific Biopharmaceuticals Limited Resolution Minerals Limited Noxopharm Limited Mad Paws Holdings Limited Peak Minerals Limited Ionic Rare Earths Limited Falcon Metals Limited Clarity Pharmaceuticals Ltd Patriot Battery Metals Inc.

Disclaimer: Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (FMP) is incorporated in Australia with limited liability. FMP and affiliated entities may have commercial or financial interests in the companies or products mentioned. This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. FMP and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to FMP and may not be used without prior consent.